Christopher M. Lindblom
No más puestos en curso
Historial de carrera de Christopher M. Lindblom
Antiguos cargos conocidos de Christopher M. Lindblom.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| INFINITY PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 25/04/2016 | 25/07/2016 |
| Treasurer | 25/07/2016 | 01/10/2016 | |
| DNIB UNWIND INC | Director Administrativo | 01/03/2014 | 21/03/2016 |
| Director Financiero/CFO | 01/03/2014 | 21/03/2016 | |
| Secretario Corporativo | 01/03/2014 | 21/03/2016 | |
| Treasurer | 01/03/2014 | 21/03/2016 | |
| INFINITY PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01/01/2006 | 12/04/2013 |
| Corporate Officer/Principal | 12/04/2013 | - | |
OvaScience, Inc.
 OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | Director Financiero/CFO | 07/06/2013 | 07/06/2013 |
| Corporate Officer/Principal | 07/06/2013 | 19/06/2013 | |
| Treasurer | 19/06/2013 | - |
Formación de Christopher M. Lindblom.
| Boston College | Masters Business Admin |
| Syracuse University | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 6 |
Operativa
| Treasurer | 3 |
| Comptroller/Controller/Auditor | 2 |
| Corporate Officer/Principal | 2 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| INFINITY PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | Health Technology |
DNIB Unwind, Inc.
 DNIB Unwind, Inc. BiotechnologyHealth Technology DNIB Unwind, Inc. develops biopharmaceutical preparations. The company was founded by Omid C. Farokhzad and Robert S. Langer on May 19, 2006 and is headquartered in Los Angeles, CA. | Health Technology |